A detailed history of Gluskin Sheff & Assoc Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Gluskin Sheff & Assoc Inc holds 9,954 shares of ZTS stock, worth $1.76 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
9,954
Previous 9,954 -0.0%
Holding current value
$1.76 Million
Previous $1.73 Million 12.7%
% of portfolio
0.24%
Previous 0.21%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$145.54 - $178.83 $15,572 - $19,134
-107 Reduced 1.06%
9,954 $1.73 Million
Q1 2024

May 15, 2024

SELL
$165.67 - $199.94 $325,044 - $392,282
-1,962 Reduced 16.32%
10,061 $1.7 Million
Q4 2023

Feb 14, 2024

SELL
$151.44 - $200.09 $555,179 - $733,529
-3,666 Reduced 23.37%
12,023 $2.37 Million
Q3 2023

Nov 14, 2023

SELL
$167.14 - $192.77 $339,294 - $391,323
-2,030 Reduced 11.46%
15,689 $2.73 Million
Q2 2023

Aug 14, 2023

SELL
$160.94 - $186.23 $436,791 - $505,428
-2,714 Reduced 13.28%
17,719 $3.05 Million
Q1 2023

May 15, 2023

SELL
$145.48 - $175.02 $224,330 - $269,880
-1,542 Reduced 7.02%
20,433 $3.4 Million
Q4 2022

Feb 14, 2023

BUY
$131.14 - $157.47 $29,113 - $34,958
222 Added 1.02%
21,975 $3.22 Million
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $31,734 - $39,065
-214 Reduced 0.97%
21,753 $3.23 Million
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $36,496 - $46,821
-234 Reduced 1.05%
21,967 $3.78 Million
Q1 2022

May 16, 2022

SELL
$181.39 - $234.03 $12,697 - $16,382
-70 Reduced 0.31%
22,201 $4.19 Million
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $41,643 - $53,111
215 Added 0.97%
22,271 $5.44 Million
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $6,246 - $6,919
33 Added 0.15%
22,056 $4.28 Million
Q2 2021

Aug 13, 2021

BUY
$155.9 - $187.99 $12,160 - $14,663
78 Added 0.36%
22,023 $4.1 Million
Q1 2021

May 14, 2021

SELL
$144.0 - $169.39 $7,920 - $9,316
-55 Reduced 0.25%
21,945 $3.46 Million
Q4 2020

Feb 16, 2021

BUY
$157.07 - $174.35 $1,256 - $1,394
8 Added 0.04%
22,000 $3.64 Million
Q3 2020

Nov 12, 2020

SELL
$137.1 - $165.37 $49,356 - $59,533
-360 Reduced 1.61%
21,992 $3.64 Million
Q2 2020

Aug 11, 2020

SELL
$111.92 - $142.53 $187,130 - $238,310
-1,672 Reduced 6.96%
22,352 $3.06 Million
Q1 2020

May 13, 2020

BUY
$92.66 - $144.94 $29,095 - $45,511
314 Added 1.32%
24,024 $2.83 Million
Q4 2019

Feb 12, 2020

SELL
$116.25 - $133.25 $18,367 - $21,053
-158 Reduced 0.66%
23,710 $3.07 Million
Q3 2019

Nov 08, 2019

BUY
$112.57 - $128.43 $2.69 Million - $3.07 Million
23,868 New
23,868 $2.97 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Gluskin Sheff & Assoc Inc Portfolio

Follow Gluskin Sheff & Assoc Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gluskin Sheff & Assoc Inc, based on Form 13F filings with the SEC.

News

Stay updated on Gluskin Sheff & Assoc Inc with notifications on news.